reviewJournal of Pharmacology and Experimental TherapeuticsNov 16, 2005Closed access

Role of Tyrosine Kinase Inhibitors in Cancer Therapy

AAAmit AroraESEric Scholar

Nebraska Medical Center · University of Nebraska Medical Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,014
total citations
FWCI
17.42
Percentile
100%
References
98
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Lapatinib
  • Medicine
  • Gefitinib
  • Tyrosine kinase
  • Erlotinib
  • Pharmacology
  • Sorafenib
  • Targeted therapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.